作者:Miyuki Kumazawa、Manabu Tejima、Miwa Fukuda、Shota Takeda、Kenji Suzuki、Yukiko Mizumoto、Kakeru Sato、Minoru Waki、Hiroyuki Miyachi、Akira Asai、Osamu Takikawa、Tomoko Hashimoto、Osamu Ohno、Kenji Matsuno
DOI:10.1021/acsmedchemlett.0c00527
日期:2021.2.11
2-alkylthio-oxazolines 3a and 3b, respectively, are a novel scaffold for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. Derivatization of the carbonothioates enhanced inhibitory activity against IDO1 and cellular kynurenine production without cytotoxicity and led to the discovery of the related scaffolds carbonodithioates 5 and cyanocarbonimidodithioates 6 as IDO1 inhibitors. Incorporation of an OH group provided
一项构效关系研究出人意料地表明,通过 2-烷硫基-恶唑啉3a和3b的独特碱性水解分别获得的硫代碳酸酯4a和4b是吲哚胺 2,3-双加氧酶 1 (IDO1) 抑制剂的新型支架。硫代碳酸盐的衍生化增强了对 IDO1 和细胞犬尿氨酸产生的抑制活性,而没有细胞毒性,并导致发现相关的支架碳二硫代酸盐5和氰基碳亚胺二硫代酸盐6作为 IDO1 抑制剂。加入 OH 基团提供了最有效的类似物5i. Soret 带的紫外-可见吸收光谱以及对接和肽图研究表明,这些分子与 IDO1 活性位点的血红素结合。我们独特的 IDO1 抑制剂是未来发展的潜在线索。